Scalper1 News
Specialty drugmaker Allergan (AGN) confirmed Thursday that it’s in “preliminary friendly discussions” on a possible buyout by big pharma Pfizer (PFE), as Wall Street poured on favorable opinions of the combination. Late Wednesday, an anonymously sourced report in the Wall Street Journal said that Pfizer and Allergan were in buyout talks, setting off a round of speculation and calculation. The news wasn’t totally shocking, since Pfizer CEO Ian Read Scalper1 News
Scalper1 News